Physiological parameters governing the action of pancreatic lipase

Nutrition Research Reviews

Volumn 23, Issue 1, 2010, Pages 146-154

  Brownlee, Iain A ^a   Forster, Deborah J ^a   Wilcox, Matthew D ^a   Dettmar, Peter W ^b   Seal, Chris J ^c   Pearson, Jeff P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Technostics Limited   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Colipase; Gastrointestinal enzymes; Lipolysis; Pancreatic lipase; Small intestine

Indexed keywords

BILE SALT; CALCIUM ION; CHOLECYSTOKININ; COLIPASE; SECRETIN; TRIACYLGLYCEROL LIPASE; BILE ACID; CALCIUM; CATION; ENZYME INHIBITOR; LACTONE; TETRAHYDROLIPSTATIN;

ACINAR CELL; ARTICLE; BERRY; BIOCATALYSIS; DUODENUM; ENZYME ACTIVITY; ENZYME BINDING; ENZYME RELEASE; HUMAN; HYDROLYSIS; INTRACELLULAR SIGNALING; LIPID ABSORPTION; LIPOLYSIS; PANCREAS JUICE; PHYSIOLOGICAL PROCESS; SEAWEED; SMALL INTESTINE; STOMACH PH; TEA; TELEMETRY; CHEMISTRY; DIGESTION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INTESTINE; INTESTINE ABSORPTION; LIPID METABOLISM; METABOLISM; PANCREAS; PH; PHYSIOLOGY; REVIEW; SECRETION;

BILE ACIDS AND SALTS; CALCIUM; CATIONS; CHOLECYSTOKININ; COLIPASES; DIGESTION; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; INTESTINE, SMALL; INTESTINES; LACTONES; LIPASE; LIPID METABOLISM; LIPOLYSIS; PANCREAS; SECRETIN;

EID: 77957275202     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422410000028     Document Type: Article

References (111)

1. Embleton JK & Pouton CW (1997) Structure and function of gastro-intestinal lipases. Adv Drug Deliv Rev 25, 15-32.
2. Palmer LS (1922) The influence of various antiseptics on the activity of lipase. J Am Chem Soc 44, 1527-1538.
3. Lowe ME, Rosenblum JL & Strauss AW (1989) Cloning and characterization of human pancreatic lipase cDNA. J Biol Chem 264, 20042-20048. (Pubitemid 20008122)
4. Winkler FK, DArcy A & Hunziker W (1990) Structure of human pancreatic lipase. Nature 343, 771-774. (Pubitemid 20065257)
5. Van Tilbeurgh H, Bezzine S, Cambillau C, et al. (1999) Colipase: structure and interaction with pancreatic lipase. Biochim Biophys Acta 1441, 173-184. (Pubitemid 29537737)
6. Lowe ME (2000) Properties and function of pancreatic lipase related protein 2. Biochimie 82, 997-1004.
7. Giller T, Buchwald P, Blum-Kaelin D, et al. (1992) Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity. J Biol Chem 267, 16509-16516.
8. Eydoux C, Spinelli S, Davis TL, et al. (2008) Structure of human pancreatic lipase-related protein 2 with the lid in an open conformation. Biochemistry 47, 9553-9564.
9. De Caro J, Sias B, Grandval P, et al. (2004) Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim Biophys Acta 1701, 89-99. (Pubitemid 39140788)
10. De Caro J, Carriere F, Barboni P, et al. (1998) Pancreatic lipase-related protein 1 (PLRP1) is present in the pancreatic juice of several species. Biochim Biophys Acta 387, 331-341. (Pubitemid 28529234)
11. Crenon I, Jayne S, Kerfelec B, et al. (1998) Pancreatic lipase-related protein type 1: a double mutation restores a significant lipase activity. Biochem Biophys Res Comm 246, 513-517. (Pubitemid 28412633)
12. Carriere F, Withers-Martinez C, Van Tilbeurgh H, et al. (1998) Structural basis for the substrate selectivity of pancreatic lipases and some related proteins. Biochim Biophys Acta 1376, 417-432. (Pubitemid 28517890)
13. Berton A, Sebban-Kreuzer C & Crenon I (2007) Role of the structural domains in the functional properties of pancreatic lipase-related protein 2. FEBS J 274, 6011-6023. (Pubitemid 350045811)
14. Miled N, Canaan S, Dupuis L, et al. (2000) Digestive lipases: from three-dimensional structure to physiology. Biochimie 82, 973-986.
15. Beisson F, Tiss A, Riviere C, et al. (2000) Methods for lipase detection and assay: a critical review. Eur J Lipid Sci Technol 102, 133-153.
16. Yadav D, Agarwal N & Pitchumoni CS (2002) A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 97, 1309-1318. (Pubitemid 34664770)
17. Ferrone M, Raimondo M & Scolapio JS (2007) Pancreatic enzyme pharmacotherapy. Pharmacotherapy 27, 910-920. (Pubitemid 46849433)
18. Hadvary P, Sidler W, Meister W, et al. (1991) The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J Biol Chem 266, 2021-2027. (Pubitemid 21909023)
19. Padwal RS & Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369, 71-77.
20. Sjostrom L, Rissanen A, Andersen T, et al. (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352, 167-172. (Pubitemid 28327800)
21. Torgerson JS, Hauptman J, Boldrin MN, et al. (2004) XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27, 155-161. (Pubitemid 38196725)
22. Finer N, James WPT, Kopelman PG, et al. (2000) One-year treatment of obesity: a randomized, double-blind, placebocontrolled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes 24, 306-313. (Pubitemid 30137720)
23. Davidson MH, Hauptman J, DiGirolamo M, et al. (1999) Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 281, 235-242. (Pubitemid 29058112)
24. Rossner S, Sjostrom L, Noack R, et al. (2000) Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 8, 49-61.
25. Elfhag K, Finer N & Rossner S (2008) Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab 10, 498-505. (Pubitemid 351639093)
26. Cavaliere H, Floriano I & Medeiros-Neto G (2001) Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes 25, 1095-1099. (Pubitemid 32566068)
27. Wäsle B & Edwardson JM (2002) The regulation of exocytosis in the pancreatic acinar cell. Cell Signal 14, 191-197. (Pubitemid 34102447)
28. Williams JA (2001) Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 63, 77-97.
29. Thevenod F (2002) Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins. Am J Physiol Cell Physiol 283, C651-C672. (Pubitemid 34920299)
30. Maouyo D & Morisset J (1995) Amazing pancreas: specific regulation of pancreatic secretion of individual digestive enzymes in rats. Am J Physiol Endocrinol Metab 268, E349-E359.
31. Crawley JN (1994) Biological actions of cholecystokinin. Peptides 15, 731-755.
32. Wank SA (1995) Cholecystokinin receptors. Am J Physiol Gastrointest Liver Physiol 269, G628-G646. (Pubitemid 3005920)
33. Power ML & Schulkin J (2008) Anticipatory physiological regulation in feeding biology: cephalic phase responses. Appetite 50, 194-206. (Pubitemid 351296337)
34. Keller J, Groger G, Cherian L, et al. (2001) Circadian coupling between pancreatic secretion and intestinal motility in humans. Am J Physiol Gastrointest Liver Physiol 280, G273-G278. (Pubitemid 32466167)
35. Domínguez-Muñoz JE, Bregulla M, Nelson DK, et al. (1998) Independent cycles of exocrine pancreatic secretion, hormones and gastroduodenal motility in healthy fasting humans: reassessment of a complex partnership. Neurogastroenterol Motil 10, 27-34. (Pubitemid 28056789)
36. Keller J, Runzi M, Goebell H, et al. (1997) Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol Gastrointest Liver Physiol 272, G632-G637. (Pubitemid 27147366)
37. Chey WY, Lee KY, Chang TM, et al. (1984) Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs. Am J Physiol 246, G248-G252. (Pubitemid 14121780)
38. Konturek SJ, Konturek JW & Domschke S (1986) Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs. Hepatogastroenterology 33, 170-175. (Pubitemid 16052380)
39. Adrian TE, Besterman HS & Mallinson CN (1979) Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. Gut 20, 37-40. (Pubitemid 9120967)
40. Wettergren A, Schjoldager B, Mortensen PE, et al. (1993) Effect of GLP-1 on gastric motility and gastric and pancreatic secretion in man. Digestion 54, 384-385. (Pubitemid 24002680)
41. Wettergren A, Schjoldager B, Mortensen PE, et al. (1993) Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38, 665-673. (Pubitemid 23121274)
42. Konturek SJ, Zabielski R, Konturek JW, et al. (2003) Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol 481, 1-14. (Pubitemid 37456781)
43. Symersky T, Biemond I, Frolich M, et al. (2005) Effect of peptide YY on pancreatico-biliary secretion in humans. Scand J Gastroenterol 40, 944-949. (Pubitemid 41117019)
44. Perona JS & Ruiz-Guttierez V (2004) Analysis of neutral lipids: triacylglycerols. In Handbook of Food Analysis: Physical Characterization and Nutrient Analysis, pp. 275-313 [LML Nollet, editor]. London: CRC Press.
45. Colin DY, Deprez-Beauclair P, Allouche M, et al. (2008) Exploring the active site cavity of human pancreatic lipase. Biochem Biophys Res Commun 370, 394-398.
46. Van Tilbeurgh H, Egloff MP, Martinez C, et al. (1993) Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature 362, 814-820. (Pubitemid 23132155)
47. Dockray GJ, Varro A, Dimaline R, et al. (2001) The gastrins: their production and biological activities. Annu Rev Physiol 63, 119-139. (Pubitemid 32304314)
48. Hersey SJ & Sachs G (1995) Gastric acid secretion. Physiol Rev 75, 155-189.
49. Allen A, Flemstrom G, Garner A, et al. (1993) Gastroduodenal mucosal protection. Physiol Rev 73, 823-857. (Pubitemid 24004654)
50. Isenberg JI, Hogan DL, Koss MA, et al. (1986) Human duodenal mucosal bicarbonate secretion. Evidence for basal secretion and stimulation by hydrochloric acid and a synthetic prostaglandin E1 analogue. Gastroenterology 91, 370-378.
51. Nyberg B (1994) Effects of intravenous infusion of secretin on bile secretion in humans. Eur J Gastroenterol Hepatol 6, 931-936. (Pubitemid 24287916)
52. Ochi K, Harada H, Mizushima T, et al. (1997) Intraductal secretin test is as useful as duodenal secretin test in assessing exocrine pancreatic function. Dig Dis Sci 42, 492-496. (Pubitemid 27148332)
53. Stevens T, Conwell DL, Zuccaro G, et al. (2004) Electrolyte composition of endoscopically collected duodenal drainage fluid after synthetic porcine secretin stimulation in healthy subjects. Gastrointest Endosc 60, 351-355. (Pubitemid 39164241)
54. Allen A & Flemström G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288, C1-C19. (Pubitemid 39658422)
55. Saetre SS, Andersen NJ, Houe T, et al. (1998) Regulation of porcine biliary secretion by secretin. Acta Physiol Scand 163, 113-119. (Pubitemid 28264350)
56. Ulrich CD II, Holtmann M & Miller LJ (1998) Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114, 382-397. (Pubitemid 28093547)
57. Muller M & Jansen PLM (1997) Molecular aspects of hepatobiliary transport. Am J Physiol Gastrointest Liver Physiol 272, G1285-G1303. (Pubitemid 27291428)
58. Ferdinandusse S & Houten SM (2006) Peroxisomes and bile acid biosynthesis. Biochim Biophys Acta 1763, 1427-1440. (Pubitemid 44880477)
59. Kullak-Ublick GA, Stieger B & Meier PJ (2004) Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322-342. (Pubitemid 38040747)
60. Borgstrom B & Erlanson C (1973) Pancreatic lipase and co lipase. Interactions and effects of bile salts and other detergents. Eur J Biochem 37, 60-68. (Pubitemid 8211142)
61. Tiss A, Ransac S, Lengsfeld H, et al. (2001) Surface behaviour of bile salts and tetrahydrolipstatin at air/water and oil/water interfaces. Chem Phys Lipids 111, 73-85. (Pubitemid 32595645)
62. Coleman R (1987) Biochemistry of bile secretion. Biochem J 244, 249-261. (Pubitemid 17087087)
63. Schmidt WE, Creutzfeldt W, Schleser A, et al. (1991) Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol Gastrointest Liver Physiol 260, G197-G206.
64. Niebergall-Roth E, Teyssen S & Singer MV (1997) Neurohormonal control of gallbladder motility. Scand J Gastroenterol 32, 737-750. (Pubitemid 27357423)
65. Knarreborg A, Jensen SK & Engberg RM (2003) Pancreatic lipase activity as influenced by unconjugated bile acids and pH, measured in vitro and in vivo. J Nutr Biochem 14, 259-265. (Pubitemid 36794263)
66. Gargouri Y, Julien R, Bois AG, et al. (1983) Studies on the detergent inhibition of pancreatic lipase activity. J Lipid Res 24, 1336-1342.
67. Patton JS&CareyMC(1981) Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles. Am J Physiol Gastrointest Liver Physiol 4, 328-336.
68. Kerfelec B, Allouche M, Colin D, et al. (2008) Computational study of colipase interaction with lipid droplets and bile salt micelles. Proteins 73, 828-838.
69. Cordle RA & Lowe ME (1998) Purification and characterization of human procolipase expressed in yeast cells. Protein Expr Purif 13, 30-35. (Pubitemid 28360342)
70. Okada S, York DA, Bray GA, et al. (1991) Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav 49, 1185-1189.
71. DAgostino D, Cordle RA, Kullman J, et al. (2002) Decreased postnatal survival and altered body weight regulation in procolipase-deficient mice. J Biol Chem 277, 7170-7177. (Pubitemid 34953107)
72. Dahim M & Brockman H (1998) How colipase-fatty acid interactions mediate adsorption of pancreatic lipase to interfaces. Biochemistry 37, 8369-8377. (Pubitemid 28275455)
73. Sugar IP, Mizuno NK, Momsen MM, et al. (2001) Lipid lateral organization in fluid interfaces controls the rate of colipase association. Biophys J 81, 3387-3397.
74. Borgstrom B (1980) Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat. In vitro experiments with the porcine enzymes. Gastroenterology 78, 954-962.
75. Cordle RA & Lowe ME (1998) The hydrophobic surface of colipase influences lipase activity at an oil-water interface. J Lipid Res 39, 1759-1767.
76. Dominguez C, Sebban-Kreuzer C, Bornet O, et al. (2000) Interactions of bile salt micelles and colipase studied through intermolecular nOes. FEBS Lett 482, 109-112.
77. Lessinger JM, Férard G, Mignot V, et al. (1996) Catalytic properties and stability of lipase purified from human pancreatic juice. Clin Chim Acta 251, 119-129. (Pubitemid 26227632)
78. Kimura H, Futami Y, Tarui S, et al. (1982) Activation of human pancreatic lipase activity by calcium and bile salts. J Biochem 92, 243-251. (Pubitemid 13067746)
79. Alvarez FJ & Stella VJ (1989) The role of calcium ions and bile salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin. Pharm Res 6, 449-457.
80. Wickham M, Garrood M, Leney J, et al. (1998) Modification of a phospholipid stabilized emulsion interface by bile salt: effect on pancreatic lipase activity. J Lipid Res 39, 623-632. (Pubitemid 28158404)
81. Dockray GJ (2003) Luminal sensing in the gut: an overview. J Physiol Pharmacol 54, Suppl. 4, 9-17.
82. Sternini C, Anselmi L & Rozengurt E (2008) Enteroendocrine cells: a site of taste in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes 15, 73-78.
83. Liddle RA (2000) Regulation of cholecystokinin secretion in humans. J Gastroenterol 35, 181-187.
84. McLaughlin J, Luca MG, Jones MN, et al. (1999) Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116, 46-53. (Pubitemid 29013492)
85. Holst JJ, Lauritzen K & Jensen SL (1981) Secretin release from the isolated, vascularly perfused pig duodenum. J Physiol 318, 327-337. (Pubitemid 11059735)
86. Nishiwaki H, Satake K & Kitamura T (1983) Postprandial plasma secretin response in patients following gastrectomy. Surg Gynecol Obstet 156, 69-72. (Pubitemid 13217999)
87. Owyang C, Louie DS & Tatum D (1986) Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 77, 2042-2047. (Pubitemid 16062662)
88. Ihse I, Lilja P & Lundquist I (1977) Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion 15, 303-308. (Pubitemid 8120787)
89. Owyang C, May D & Louie DS (1986) Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology 91, 637-643.
90. Layer P, Jansen JBMJ, Cherian L, et al. (1990) Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. Gastroenterology 98, 1311-1319.
91. Ben Rebah F, Smaoui S, Frikha F, et al. (2008) Inhibitory effects of Tunisian marine algal extracts on digestive lipases. Appl Biochem Biotechnol 151, 71-79.
92. Bitou N, Ninomiya M, Tsujita T, et al. (1999) Screening of lipase inhibitors from marine algae. Lipids 34, 441-445. (Pubitemid 29262588)
93. Koo SI & Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18, 179-183.
94. McDougall GJ, Kulkarni NN & Stewart D (2009) Berry polyphenols inhibit pancreatic lipase activity in vitro. Food Chem 115, 193-199.
95. Tani H, Ohishi H & Watanabe K (1995) When flour lipase inhibitor decreases serum lipid levels in male rats. J Nutr Sci Vitaminol 41, 699-706.
96. Birari RB & Bhutani KK (2007) Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 12, 879-889.
97. Vogel WC & Zieve L (1963) A rapid and sensitive turbidimetric method for serum lipase based upon differences between the lipases of normal and pancreatitis serum. Clin Chem 9, 168-181.
98. Kanno N, LeSage G, Glaser S, et al. (2001) Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 281, G612-G625. (Pubitemid 32879175)
99. Steward MC, Ishiguro H & Case RM (2005) Mechanisms of bicarbonate secretion in the pancreatic duct. Ann Rev Physiol 67, 377-409. (Pubitemid 40404495)
100. Hernell O, Staggers JE & Carey MC (1990) Physicalchemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29, 2041-2056. (Pubitemid 20085429)
101. Kay GH, Tetlow VA & Braganza JM (1983) Relationship between PABA and Lundh tests: lack of influence of duodenal pH in vivo. Clin Chim Acta 128, 115-124.
102. Watson BW, Meldrum SJ, Riddle HC, et al. (1972) pH profile of gut as measured by radiotelemetry capsule. BMJ 2, 104-106.
103. Evans DF, Pye G, Bramley R, et al. (1988) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29, 1035-1041.
104. Zentler-Munro PL, Fitzpatrick WJF, Batten JC, et al. (1984) Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut 25, 500-507.
105. Fallingborg J, Christensen LA, Ingeman-Nielsen M, et al. (1989) pH-profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol Ther 3, 605-613. (Pubitemid 20118814)
106. Sasaki Y, Hada R, Nakajima H, et al. (1997) Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohns disease. Am J Gastroenterol 92, 114-118. (Pubitemid 27027040)
107. Fallingborg J, Pedersen P & Jacobsen BA (1998) Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohns disease. Dig Dis Sci 43, 702-705. (Pubitemid 28176455)
108. Press AG, Hauptmann IA, Hauptmann L, et al. (1998) Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther 12, 673-678. (Pubitemid 28327965)
109. Brouwers J, Ingels F, Tack J, et al. (2005) Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form. J Pharm Pharmacol 57, 987-995. (Pubitemid 41039833)
110. Perez De La Cruz Moreno M, Oth M, Deferme S, et al. (2006) Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 58, 1079-1089. (Pubitemid 44213641)
111. Ibekwe VC, Fadda HM, McConnell EL, et al. (2008) Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems. Pharm Res 25, 1828-1835.